What Went Wrong with VEGF-A in Peripheral Arterial Disease? A Systematic Review and Biological Insights on Future Therapeutics

BACKGROUND: Of the 200 million patients worldwide affected by peripheral arterial disease (PAD), 4% will inevitably require major limb amputation. Previous systematic reviews presented a conflicting body of evidence in terms of vascular endothelial growth factor (VEGF) family member effects upon PAD...

Descripción completa

Detalles Bibliográficos
Autores principales: Kastora, Stavroula L., Eley, Jonathan, Gannon, Martin, Melvin, Ross, Munro, Euan, Makris, Sotirios A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Methods in Vascular Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808638/
https://www.ncbi.nlm.nih.gov/pubmed/36380643
http://dx.doi.org/10.1159/000527079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808638/
https://www.ncbi.nlm.nih.gov/pubmed/36380643
http://dx.doi.org/10.1159/000527079

Ejemplares similares